Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2002
12/27/2002CA2782623A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782615A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782521A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782519A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782517A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782515A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782494A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002CA2449909A1 Male contraceptives
12/27/2002CA2449898A1 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/27/2002CA2449212A1 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/26/2002US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002US20020198234 Identifying a patient suffering from fatigue arising from oncological condition, and administering to the patient a therapeutically effective amount of D-threo-methylphenidate free of 1-threo isomer
12/26/2002US20020198223 Pharmaceutically active compounds
12/26/2002US20020198196 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
12/26/2002US20020198187 Method of treating sexual disturbances
12/26/2002US20020198177 Coenzyme Q and EPA
12/26/2002US20020198164 A toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence
12/26/2002US20020198155 Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders
12/26/2002US20020198152 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor
12/26/2002US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
12/26/2002US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002US20020198136 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc.
12/25/2002CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002CN1387528A Heterocyclic substd, pyrazolones
12/25/2002CN1387444A Method of treatment using anti-ErbB antibody-maytansinoid conjugates
12/25/2002CN1387432A Methods of sing rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfnction
12/25/2002CN1386540A Medicine for treating mastropathy by exteriorly applying to acupoints
12/25/2002CN1386522A Medicine for treating impotence and its preparing process
12/25/2002CN1386520A Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma
12/25/2002CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof
12/25/2002CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/24/2002US6498243 Epimorphin antagonist and process for producing it
12/24/2002US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile
12/24/2002US6498154 Cyclic regimens using quinazolinone and benzoxazine derivatives
12/24/2002US6497906 Anticholesterol, reduced menstrual bleeding
12/24/2002US6497869 Having a ph of 5.0 to 8.0, and a salt comprising sulfate ions; treatment of shipping fever, bovine mastitis
12/24/2002CA2222133C Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
12/24/2002CA2075878C Cyclic peptides and use thereof
12/21/2002CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions
12/19/2002WO2002101392A2 Methods for treating disorders of the nervous and reproductive systems
12/19/2002WO2002101357A2 Molecular signatures of commonly fatal carcinomas
12/19/2002WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002WO2002101008A2 Intracellular signaling molecules
12/19/2002WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002WO2002100888A1 Somatostatin-dopamine chimeric analogs
12/19/2002WO2002100865A1 Benzoxazepine derivatives and their use as ampa receptor stimulators
12/19/2002WO2002100859A1 Pde iv inhibitors
12/19/2002WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002WO2002100422A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/19/2002WO2002100377A1 PHARMACEUTICAL FORMULATION FOR THE EFFICIENT ADMINISTRATION OF APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND THEIR DERIVATIVES AND PRO-DRUGS THEREOF
12/19/2002WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002WO2002088144A3 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
12/19/2002WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002WO2002080754A3 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002060428A3 Methods of using and compositions comprising (-)sibutramine optionally in combination with other pharmacologically active compounds
12/19/2002WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002WO2002005795A3 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
12/19/2002US20020193614 Treatment of cardiovascular disorders
12/19/2002US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands
12/19/2002US20020193409 Prodrugs of anticancer agents employing substituted aromatic acids
12/19/2002US20020193397 Nasal delivery of apomorphine
12/19/2002US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002US20020193359 Androgen as a male contraceptive and non-contraceptive androgen replacement
12/19/2002US20020193307 Antagonism of endothelin actions
12/19/2002US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002US20020192647 Diagnostic method
12/19/2002US20020192307 Method and composition for enhancing sexual desire
12/19/2002US20020192285 Controlled release pellet formulation
12/19/2002US20020192162 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002DE10127897A1 Combined pharmaceutical formulation for treating osteoporosis or related disorders, comprising core of dried plant extract enclosed in sheath of calcium salt
12/19/2002CA2450379A1 Molecular signatures of commonly fatal carcinomas
12/19/2002CA2449654A1 Methods for treating disorders of the nervous and reproductive systems
12/19/2002CA2449571A1 Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
12/19/2002CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002CA2449272A1 Intracellular signaling molecules
12/19/2002CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002CA2449247A1 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/18/2002EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002EP1266012A2 Proteases
12/18/2002EP1266001A2 Human transcription factors
12/18/2002EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
12/18/2002EP1265905A1 Il-8 receptor antagonists
12/18/2002EP1265903A1 Thiepino[3,2-b]dihydropyridines and related compositions and methods
12/18/2002EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002EP1265896A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
12/18/2002EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 557